{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:28:25Z","timestamp":1781522905823,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04357-z","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:46:50Z","timestamp":1764935210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["External validation, recalibration, and clinical utility of the kidney failure risk equation in patients with advanced CKD: a nationwide retrospective cohort analysis in Peru"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2528-6271","authenticated-orcid":false,"given":"Jessica Ivonne","family":"Bravo-Z\u00fa\u00f1iga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5332-9254","authenticated-orcid":false,"given":"Percy","family":"Soto-Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-6110","authenticated-orcid":false,"given":"Edgar Juan","family":"Coila-Paricahua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-0098","authenticated-orcid":false,"given":"Ricardo","family":"Ch\u00e1vez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0019-9625","authenticated-orcid":false,"given":"Eduardo","family":"P\u00e9rez-Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8910-4934","authenticated-orcid":false,"given":"Anselma Victoria","family":"Pardo-Villafranca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1319-5002","authenticated-orcid":false,"given":"Lizbeth Carmen","family":"Arce-Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4878-5399","authenticated-orcid":false,"given":"Daysi","family":"Diaz-Obreg\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"7","key":"4357_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473\u201385. https:\/\/doi.org\/10.1038\/s41581-024-00820-6.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"4357_CR2","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney Disease - A systematic review and Meta-Analysis. PLoS ONE. 2016;11(7):e0158765. https:\/\/doi.org\/10.1371\/journal.pone.0158765.","journal-title":"PLoS ONE"},{"issue":"4","key":"4357_CR3","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"key":"4357_CR4","unstructured":"Recommendations, August. 25, 2021. Accessed August 6, 2024. https:\/\/www.nice.org.uk\/guidance\/ng203\/chapter\/Recommendations#risk-assessment-referral-criteria-and-shared-care"},{"issue":"4","key":"4357_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.35663\/amp.2020.374.1843","volume":"37","author":"J Bravo-Z\u00fa\u00f1iga","year":"2020","unstructured":"Bravo-Z\u00fa\u00f1iga J, Hinostoza-Sayas J, Goicochea Lugo S, et al. Gu\u00eda de pr\u00e1ctica cl\u00ednica Para El tamizaje, Diagn\u00f3stico y Manejo de La Enfermedad renal cr\u00f3nica En estadios 1 al 3 En El Seguro social Del Per\u00fa (EsSalud). Acta M\u00e9dica Peruana. 2020;37(4):518\u201331. https:\/\/doi.org\/10.35663\/amp.2020.374.1843.","journal-title":"Acta M\u00e9dica Peruana"},{"issue":"1","key":"4357_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.35434\/rcmhnaaa.2023.161.1709","volume":"16","author":"J Bravo-Z\u00fa\u00f1iga","year":"2023","unstructured":"Bravo-Z\u00fa\u00f1iga J, Garcia-Gomero D, Dolores-Maldonado G, et al. Gu\u00eda de pr\u00e1ctica cl\u00ednica Para El Manejo de La Enfermedad renal cr\u00f3nica estad\u00edos 3b, 4 y 5 En El Seguro social de Salud Del Per\u00fa (EsSalud). Revista Del Cuerpo M\u00e9dico Hosp Nac Almanzor Aguinaga Asenjo. 2023;16(1):102\u201311. https:\/\/doi.org\/10.35434\/rcmhnaaa.2023.161.1709.","journal-title":"Revista Del Cuerpo M\u00e9dico Hosp Nac Almanzor Aguinaga Asenjo"},{"key":"4357_CR7","unstructured":"Chronic Kidney Disease in Adults: Assessment and Management. National Institute for Health and Care Excellence (NICE). 2015. Accessed September 16, 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK555204\/"},{"key":"4357_CR8","doi-asserted-by":"crossref","unstructured":"Inserra F, Torres ML, Alles A, et al. Especial atenci\u00f3n sobre situaciones cl\u00ednicas espec\u00edficas. Acta Bioqu\u00edmica Cl\u00ednica Latinoam. 2022;56(1):43\u201374. Evaluaci\u00f3n de la funci\u00f3n renal para la detecci\u00f3n y seguimiento de la enfermedad renal cr\u00f3nica. Documento multidisciplinario de consenso 2021.","DOI":"10.62073\/bypc.v86i1.203"},{"key":"4357_CR9","doi-asserted-by":"publisher","first-page":"e074819","DOI":"10.1136\/bmj-2023-074819","volume":"384","author":"GS Collins","year":"2024","unstructured":"Collins GS, Dhiman P, Ma J, et al. Evaluation of clinical prediction models (part 1): from development to external validation. BMJ. 2024;384:e074819. https:\/\/doi.org\/10.1136\/bmj-2023-074819.","journal-title":"BMJ"},{"key":"4357_CR10","doi-asserted-by":"publisher","first-page":"e074820","DOI":"10.1136\/bmj-2023-074820","volume":"384","author":"RD Riley","year":"2024","unstructured":"Riley RD, Archer L, Snell KIE, et al. Evaluation of clinical prediction models (part 2): how to undertake an external validation study. BMJ. 2024;384:e074820. https:\/\/doi.org\/10.1136\/bmj-2023-074820.","journal-title":"BMJ"},{"issue":"1","key":"4357_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","volume":"13","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med. 2015;13(1):1. https:\/\/doi.org\/10.1186\/s12916-014-0241-z.","journal-title":"BMC Med"},{"issue":"4","key":"4357_CR12","doi-asserted-by":"publisher","first-page":"100440","DOI":"10.1016\/j.xkme.2022.100440","volume":"4","author":"SJ Thanabalasingam","year":"2022","unstructured":"Thanabalasingam SJ, Iliescu EA, Norman PA, et al. Independent external validation and comparison of death and kidney replacement therapy prediction models in advanced CKD. Kidney Med. 2022;4(4):100440. https:\/\/doi.org\/10.1016\/j.xkme.2022.100440.","journal-title":"Kidney Med"},{"issue":"10","key":"4357_CR13","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.2215\/CJN.03940320","volume":"15","author":"GL Hundemer","year":"2020","unstructured":"Hundemer GL, Tangri N, Sood MM, et al. Performance of the kidney failure risk equation by disease etiology in advanced CKD. Clin J Am Soc Nephrol. 2020;15(10):1424\u201332. https:\/\/doi.org\/10.2215\/CJN.03940320.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"4357_CR14","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/ndt\/gft063","volume":"28","author":"MJ Peeters","year":"2013","unstructured":"Peeters MJ, van Zuilen AD, van den Brand JAJG, et al. Validation of the kidney failure risk equation in European CKD patients. Nephrol Dial Transpl. 2013;28(7):1773\u20139. https:\/\/doi.org\/10.1093\/ndt\/gft063.","journal-title":"Nephrol Dial Transpl"},{"key":"4357_CR15","doi-asserted-by":"publisher","first-page":"205435811770537","DOI":"10.1177\/2054358117705372","volume":"4","author":"RH Whitlock","year":"2017","unstructured":"Whitlock RH, Chartier M, Komenda P, et al. Validation of the kidney failure risk equation in Manitoba. Can J Kidney Health Dis. 2017;4:2054358117705372. https:\/\/doi.org\/10.1177\/2054358117705372.","journal-title":"Can J Kidney Health Dis"},{"issue":"5","key":"4357_CR16","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1681\/ASN.2020071077","volume":"32","author":"CL Ramspek","year":"2021","unstructured":"Ramspek CL, Evans M, Wanner C, et al. Kidney failure prediction models: A comprehensive external validation study in patients with advanced CKD. J Am Soc Nephrol. 2021;32(5):1174\u201386. https:\/\/doi.org\/10.1681\/ASN.2020071077.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"4357_CR17","doi-asserted-by":"publisher","first-page":"e1002955","DOI":"10.1371\/journal.pmed.1002955","volume":"16","author":"RW Major","year":"2019","unstructured":"Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ. The kidney failure risk equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study. PLoS Med. 2019;16(11):e1002955. https:\/\/doi.org\/10.1371\/journal.pmed.1002955.","journal-title":"PLoS Med"},{"issue":"9","key":"4357_CR18","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/ndt\/gfv089","volume":"30","author":"A Marks","year":"2015","unstructured":"Marks A, Fluck N, Prescott GJ, et al. Looking to the future: predicting renal replacement outcomes in a large community cohort with chronic kidney disease. Nephrol Dialysis Transplantation. 2015;30(9):1507\u201317. https:\/\/doi.org\/10.1093\/ndt\/gfv089.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"6","key":"4357_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.11622\/smedj.2020170","volume":"63","author":"JL Kwek","year":"2022","unstructured":"Kwek JL, Pang HQJ, Li H, et al. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort. Singap Med J. 2022;63(6):313\u20138. https:\/\/doi.org\/10.11622\/smedj.2020170.","journal-title":"Singap Med J"},{"issue":"1","key":"4357_CR20","doi-asserted-by":"publisher","first-page":"12920","DOI":"10.1038\/s41598-020-69715-3","volume":"10","author":"MW Kang","year":"2020","unstructured":"Kang MW, Tangri N, Kim YC, et al. An independent validation of the kidney failure risk equation in an Asian population. Sci Rep. 2020;10(1):12920. https:\/\/doi.org\/10.1038\/s41598-020-69715-3.","journal-title":"Sci Rep"},{"issue":"5","key":"4357_CR21","doi-asserted-by":"publisher","first-page":"100817","DOI":"10.1016\/j.xkme.2024.100817","volume":"6","author":"L Pan","year":"2024","unstructured":"Pan L, Wang J, Deng Y, et al. External validation of the kidney failure risk equation among urban Community-Based Chinese patients with CKD. Kidney Med. 2024;6(5):100817. https:\/\/doi.org\/10.1016\/j.xkme.2024.100817.","journal-title":"Kidney Med"},{"issue":"1","key":"4357_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s41512-023-00157-x","volume":"7","author":"F Maher","year":"2023","unstructured":"Maher F, Teece L, Major RW, et al. Using the kidney failure risk equation to predict end-stage kidney disease in CKD patients of South Asian ethnicity: an external validation study. Diagn Progn Res. 2023;7(1):22. https:\/\/doi.org\/10.1186\/s41512-023-00157-x.","journal-title":"Diagn Progn Res"},{"issue":"1","key":"4357_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12882-019-1643-0","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, Nguyen FNHL, Allen JC, Lew JQL, Tan NC, Jafar TH. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. BMC Nephrol. 2019;20(1):451. https:\/\/doi.org\/10.1186\/s12882-019-1643-0.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4357_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40620-023-01680-2","volume":"37","author":"S Jahan","year":"2024","unstructured":"Jahan S, Hale J, Malacova E, Hurst C, Kark A, Mallett A. Real world evaluation of kidney failure risk equations in predicting progression from chronic kidney disease to kidney failure in an Australian cohort. J Nephrol. 2024;37(1):231\u20137. https:\/\/doi.org\/10.1007\/s40620-023-01680-2.","journal-title":"J Nephrol"},{"issue":"2","key":"4357_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2015.18202","volume":"315","author":"N Tangri","year":"2016","unstructured":"Tangri N, Grams ME, Levey AS, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: A Meta-analysis. JAMA. 2016;315(2):164\u201374. https:\/\/doi.org\/10.1001\/jama.2015.18202.","journal-title":"JAMA"},{"issue":"2","key":"4357_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s40620-023-01819-1","volume":"37","author":"E Gallego-Valcarce","year":"2024","unstructured":"Gallego-Valcarce E, Shabaka A, Tato-Ribera AM, et al. External validation of the KFRE and grams prediction models for kidney failure and death in a Spanish cohort of patients with advanced chronic kidney disease. J Nephrol. 2024;37(2):429\u201337. https:\/\/doi.org\/10.1007\/s40620-023-01819-1.","journal-title":"J Nephrol"},{"issue":"4","key":"4357_CR27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2215\/CJN.08110715","volume":"11","author":"CS Lennartz","year":"2016","unstructured":"Lennartz CS, Pickering JW, Seiler-Mu\u00dfler S, et al. External validation of the kidney failure risk equation and Re-Calibration with addition of ultrasound parameters. Clin J Am Soc Nephrol. 2016;11(4):609\u201315. https:\/\/doi.org\/10.2215\/CJN.08110715.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"4357_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.nefroe.2022.03.007","volume":"43","author":"BM da Silva","year":"2023","unstructured":"da Silva BM, Charreu J, Duarte I, Outerelo C, Gameiro J. Validation of the kidney failure risk equation in a Portuguese cohort. Nefrologia (Engl Ed). 2023;43(4):467\u201373. https:\/\/doi.org\/10.1016\/j.nefroe.2022.03.007.","journal-title":"Nefrologia (Engl Ed)"},{"issue":"1","key":"4357_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12882-021-02402-1","volume":"22","author":"I Ali","year":"2021","unstructured":"Ali I, Donne RL, Kalra PA. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility. BMC Nephrol. 2021;22(1):194. https:\/\/doi.org\/10.1186\/s12882-021-02402-1.","journal-title":"BMC Nephrol"},{"issue":"6","key":"4357_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/nep.14160","volume":"28","author":"GL Irish","year":"2023","unstructured":"Irish GL, Cuthbertson L, Kitsos A, Saunder T, Clayton PA, Jose MD. The kidney failure risk equation predicts kidney failure: validation in an Australian cohort. Nephrol (Carlton). 2023;28(6):328\u201335. https:\/\/doi.org\/10.1111\/nep.14160.","journal-title":"Nephrol (Carlton)"},{"issue":"1","key":"4357_CR31","doi-asserted-by":"publisher","first-page":"e076217","DOI":"10.1136\/bmjopen-2023-076217","volume":"14","author":"J Bravo-Z\u00fa\u00f1iga","year":"2024","unstructured":"Bravo-Z\u00fa\u00f1iga J, Ch\u00e1vez-G\u00f3mez R, Soto-Becerra P. Multicentre external validation of the prognostic model kidney failure risk equation in patients with CKD stages 3 and 4 in peru: a retrospective cohort study. BMJ Open. 2024;14(1):e076217. https:\/\/doi.org\/10.1136\/bmjopen-2023-076217.","journal-title":"BMJ Open"},{"key":"4357_CR32","doi-asserted-by":"publisher","first-page":"1282664","DOI":"10.1155\/2024\/1282664","volume":"2024","author":"C Larrarte","year":"2024","unstructured":"Larrarte C, Vesga J, Ardila F, Aldana A, Perea D, Sanabria M. Validation of the kidney failure risk equation in the Colombian population. Int J Nephrol. 2024;2024:1282664. https:\/\/doi.org\/10.1155\/2024\/1282664.","journal-title":"Int J Nephrol"},{"issue":"4","key":"4357_CR33","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.ekir.2024.02.184","volume":"9","author":"D Gonz\u00e1lez","year":"2024","unstructured":"Gonz\u00e1lez D, Sola L, Rios P, WCN24-1069 VALIDATION OF THE KIDNEY FAILURE RISK EQUATION (KFRE) AND ITS APPLICATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE FOLLOWED BY THE RENAL HEALTH-CARE PROGRAM OF URUGUAY, et al. Kidney Int Rep. 2024;9(4):S86\u20137. https:\/\/doi.org\/10.1016\/j.ekir.2024.02.184.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"4357_CR34","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KGM Moons","year":"2015","unstructured":"Moons KGM, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1\u201373. https:\/\/doi.org\/10.7326\/M14-0698.","journal-title":"Ann Intern Med"},{"key":"4357_CR35","doi-asserted-by":"crossref","unstructured":"Steyerberg EW. Clinical prediction models: A practical approach to development, validation, and updating. 2nd ed. Springer; 2020.","DOI":"10.1007\/978-3-030-16399-0"},{"key":"4357_CR36","doi-asserted-by":"crossref","unstructured":"Harrell FE. Regression modeling strategies: With applications to linear models, logistic and ordinal regression, and survival analysis. Second edition. Springer; 2015.","DOI":"10.1007\/978-3-319-19425-7"},{"key":"4357_CR37","doi-asserted-by":"publisher","unstructured":"Austin PC. Multiple imputation with competing risk outcomes. Comput stat. Published Online June. 2024;26. https:\/\/doi.org\/10.1007\/s00180-024-01518-w.","DOI":"10.1007\/s00180-024-01518-w"},{"key":"4357_CR38","doi-asserted-by":"publisher","first-page":"e069249","DOI":"10.1136\/bmj-2021-069249","volume":"377","author":"N van Geloven","year":"2022","unstructured":"van Geloven N, Giardiello D, Bonneville EF, et al. Validation of prediction models in the presence of competing risks: a guide through modern methods. BMJ. 2022;377:e069249. https:\/\/doi.org\/10.1136\/bmj-2021-069249.","journal-title":"BMJ"},{"issue":"2","key":"4357_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/ije\/dyab256","volume":"51","author":"CL Ramspek","year":"2022","unstructured":"Ramspek CL, Teece L, Snell KIE, et al. Lessons learnt when accounting for competing events in the external validation of time-to-event prognostic models. Int J Epidemiol. 2022;51(2):615\u201325. https:\/\/doi.org\/10.1093\/ije\/dyab256.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"4357_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","volume":"3","author":"AJ Vickers","year":"2019","unstructured":"Vickers AJ, van Calster B, Steyerberg EW. A simple, step-by-step guide to interpreting decision curve analysis. Diagn Prognostic Res. 2019;3(1):18. https:\/\/doi.org\/10.1186\/s41512-019-0064-7.","journal-title":"Diagn Prognostic Res"},{"key":"4357_CR41","doi-asserted-by":"crossref","unstructured":"van Buuren S. Flexible imputation of missing data. CRC; 2012.","DOI":"10.1201\/b11826"},{"issue":"2","key":"4357_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4093\/dmj.2023.0244","volume":"48","author":"YG Ooi","year":"2024","unstructured":"Ooi YG, Sarvanandan T, Hee NKY, et al. Risk prediction and management of chronic kidney disease in people living with type 2 diabetes mellitus. Diabetes Metab J. 2024;48(2):196\u2013207. https:\/\/doi.org\/10.4093\/dmj.2023.0244.","journal-title":"Diabetes Metab J"},{"issue":"2","key":"4357_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2215\/CJN.07970718","volume":"14","author":"OA Potok","year":"2019","unstructured":"Potok OA, Nguyen HA, Abdelmalek JA, Beben T, Woodell TB, Rifkin DE. Patients,\u2019 nephrologists,\u2019 and predicted estimations of ESKD risk compared with 2-Year incidence of ESKD. Clin J Am Soc Nephrol. 2019;14(2):206\u201312. https:\/\/doi.org\/10.2215\/CJN.07970718.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"4357_CR44","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.kint.2018.01.009","volume":"93","author":"ME Grams","year":"2018","unstructured":"Grams ME, Sang Y, Ballew SH, et al. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93(6):1442\u201351. https:\/\/doi.org\/10.1016\/j.kint.2018.01.009.","journal-title":"Kidney Int"},{"issue":"3","key":"4357_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.34067\/KID.0005592020","volume":"2","author":"FS Naranjo","year":"2021","unstructured":"Naranjo FS, Sang Y, Ballew SH, et al. Estimating kidney failure risk using electronic medical records. Kidney360. 2021;2(3):415\u201324. https:\/\/doi.org\/10.34067\/KID.0005592020.","journal-title":"Kidney360"},{"issue":"3","key":"4357_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7326\/M21-2928","volume":"175","author":"JD Bundy","year":"2022","unstructured":"Bundy JD, Mills KT, Anderson AH, et al. Prediction of End-Stage kidney disease using estimated glomerular filtration rate with and without race: A prospective cohort study. Ann Intern Med. 2022;175(3):305\u201313. https:\/\/doi.org\/10.7326\/M21-2928.","journal-title":"Ann Intern Med"},{"key":"4357_CR47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1053\/j.ajkd.2014.07.026","volume":"65","author":"ME Grams","year":"2015","unstructured":"Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WHL, et al. Estimating time to ESRD using kidney failure risk equations: results from the African American study of kidney disease and hypertension (AASK). Am J Kidney Dis Off J Natl Kidney Found. 2015;65:394\u2013402.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"4357_CR48","first-page":"49","volume":"14","author":"CL Ramspek","year":"2021","unstructured":"Ramspek CL, Jager KJ, Dekker FW, Zoccali C, van Diepen M. External validation of prognostic models: what, why, how, when and where? Clin. Kidney J. 2021;14:49\u201358.","journal-title":"Kidney J"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04357-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04357-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04357-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:46:53Z","timestamp":1764935213000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04357-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4357"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04357-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5520011\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of the Edgardo Rebagliati National Hospital at EsSalud (Code No. 519-GRPR-ESSALUD-2023) and was conducted in accordance with the principles of the Declaration of Helsinki. A waiver of informed consent was granted by the Research Ethics Committee of the Edgardo Rebagliati National Hospital at EsSalud because the study involved routinely collected secondary data. Given the minimal risks associated with this type of research, this waiver was deemed a reasonable justification and was approved accordingly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not apply.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JBZ, RCG, EPT, AVPV, and LCAG are full-time employees of EsSalud, serving as nephrologists at the Nephrology Department, Hospital Edgardo Rebagliati Martins, and the National Center of Renal Health in Lima, Peru. PSB was an associated researcher at the Instituto de Evaluaci\u00f3n de Tecnolog\u00edas en Salud e Investigaci\u00f3n (IETSI), EsSalud, and has received consultancy fees from EsSalud. EJCP served as an associated researcher and Deputy Manager at IETSI, EsSalud. DDO was a full-time employee of EsSalud during the initial phases of the study. The authors affirm that their respective affiliations with EsSalud have not influenced any aspect of the study, including its design, data collection, analysis, interpretation, or manuscript preparation. Furthermore, none of the authors have any financial or personal relationships that could inappropriately influence (bias) the work reported in this manuscript. The authors declare that there are no other competing interests or potential conflicts of interest related to the content of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"688"}}